212 related articles for article (PubMed ID: 34531269)
21. Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
Lagacé-Wiens PRS; Adam HJ; Poutanen S; Baxter MR; Denisuik AJ; Golden AR; Nichol KA; Walkty A; Karlowsky JA; Mulvey MR; Golding G; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv22-iv31. PubMed ID: 31505648
[TBL] [Abstract][Full Text] [Related]
22. Cefpirome Treatment Results in Limited Selection of Stable Derepressed
Gautam V; Mouton JW; Ten Kate MT; Bakker-Woudenberg IAJM; van Burgh S; Strepis N; Klaassen CHW; Goessens W
Microb Drug Resist; 2020 Apr; 26(4):341-348. PubMed ID: 31657651
[No Abstract] [Full Text] [Related]
23. A Prolonged Outbreak of KPC-3-Producing Enterobacter cloacae and Klebsiella pneumoniae Driven by Multiple Mechanisms of Resistance Transmission at a Large Academic Burn Center.
Kanamori H; Parobek CM; Juliano JJ; van Duin D; Cairns BA; Weber DJ; Rutala WA
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919898
[TBL] [Abstract][Full Text] [Related]
24. The First Enterobacter cloacae Co-Producing NDM and OXA-48 Carbapenemases and Interhospital Spread of OXA-48 and NDM-Producing Klebsiella pneumoniae in Turkey.
Haciseyitoglu D; Dokutan A; Abulaila A; Erdem F; Cag Y; Ozer S; Aktas Z
Clin Lab; 2017 Jul; 63(7):1213-1222. PubMed ID: 28792697
[TBL] [Abstract][Full Text] [Related]
25. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
Mao T; Zhai H; Duan G; Yang H
Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
[TBL] [Abstract][Full Text] [Related]
26. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of pooled human urine and synthetic alternatives in a dynamic bladder infection in vitro model simulating oral fosfomycin therapy.
Abbott IJ; van Gorp E; Wijma RA; Meletiadis J; Mouton JW; Peleg AY
J Microbiol Methods; 2020 Apr; 171():105861. PubMed ID: 32035114
[TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
[TBL] [Abstract][Full Text] [Related]
29. [Report of antimicrobial resistance surveillance program in Chinese children in 2016].
Wang CQ; Wang AM; Yu H; Xu HM; Jing CM; Deng JK; Zhao RZ; Hua CZ; Chen YH; Chen XJ; Zhang T; Zhang H; Chen YP; Yang JG; Lin AW; Wang SF; Cao Q; Wang X; Deng HL; Cao SC; He JH; Gao W; Han SZ
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):29-33. PubMed ID: 29342994
[No Abstract] [Full Text] [Related]
30. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China.
Zhang X; Qu F; Jia W; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H
Int J Antimicrob Agents; 2021 Feb; 57(2):106262. PubMed ID: 33347990
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
[TBL] [Abstract][Full Text] [Related]
32. Enterobacter and Klebsiella species isolated from fresh vegetables marketed in Valencia (Spain) and their clinically relevant resistances to chemotherapeutic agents.
Falomir MP; Rico H; Gozalbo D
Foodborne Pathog Dis; 2013 Dec; 10(12):1002-7. PubMed ID: 23980710
[TBL] [Abstract][Full Text] [Related]
33. Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates.
Miró E; Segura C; Navarro F; Sorlí L; Coll P; Horcajada JP; Alvarez-Lerma F; Salvadó M
J Antimicrob Chemother; 2010 Apr; 65(4):661-5. PubMed ID: 20089541
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Jean SS; Ko WC; Hsueh PR;
Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
36. Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012-2013).
Zalacain M; Biedenbach DJ; Badal RE; Young K; Motyl M; Sahm DF
Clin Ther; 2016 Jun; 38(6):1510-1521. PubMed ID: 27234360
[TBL] [Abstract][Full Text] [Related]
37. Transferrable resistance to tobramycin in Klebsiella pneumoniae and Enterobacter cloacae associated with enzymatic acetylation of tobramycin.
Minshew BH; Holmes RK; Sanford JP; Baxter CR
Antimicrob Agents Chemother; 1974 Oct; 6(4):492-7. PubMed ID: 4157351
[TBL] [Abstract][Full Text] [Related]
38. Role of IncHI2 plasmids harbouring blaVIM-1, blaCTX-M-9, aac(6')-Ib and qnrA genes in the spread of multiresistant Enterobacter cloacae and Klebsiella pneumoniae strains in different units at Hospital Vall d'Hebron, Barcelona, Spain.
Coelho A; Piedra-Carrasco N; Bartolomé R; Quintero-Zarate JN; Larrosa N; Cornejo-Sánchez T; Prats G; Garcillán-Barcia MP; de la Cruz F; González-Lopéz JJ
Int J Antimicrob Agents; 2012 Jun; 39(6):514-7. PubMed ID: 22481058
[TBL] [Abstract][Full Text] [Related]
39. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
Huang SR; Liu MF; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
[TBL] [Abstract][Full Text] [Related]
40. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options.
Origüen J; Fernández-Ruiz M; López-Medrano F; Ruiz-Merlo T; González E; Morales JM; Fiorante S; San-Juan R; Villa J; Orellana MÁ; Andrés A; Aguado JM
Transpl Infect Dis; 2016 Aug; 18(4):575-84. PubMed ID: 27373698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
